IJPR.2025.122
Type of Article: Original Research
Volume 13; Issue 2 (August 2025)
Page No.: 4869-4876
DOI: https://dx.doi.org/10.16965/ijpr.2025.122
Prevalence of Neurological Complications amongst Post-COVID-19 Patients Using the Edinburgh Questionnaire: A Cross-Sectional Study in Chhatrapati Sambhajinagar, Maharashtra
Garvisha Sudhir Janorkar *1, Quazi Ibtesaam Huma 2.
1* Undergraduate Student of Shiva Trust’s Aurangabad College of Physiotherapy, India.
2 Assistant Professor, Department of Physiotherapy in Neurosciences, Shiva Trust’s Aurangabad College of Physiotherapy, Aurangabad, India.
Address for correspondence: Garvisha Sudhir Janorkar, Undergraduate student of Shiva Trust’s Aurangabad College of Physiotherapy, Aurangabad, India. Email: garvishajanorkar8309@gmail.com
ABSTRACT
Background: The COVID-19 pandemic has led to significant long-term effects beyond respiratory illness, notably involving the nervous system. Increasing evidence indicates that post-COVID-19 syndrome can present with a range of neurological complications. This study aimed to assess the prevalence and awareness of neurological complications among post-COVID-19 patients using the Edinburgh Neuro-symptoms Questionnaire.
Aim: To observe the prevalence of Neurological Complications among Post-COVID 19 patients using Edinburgh Questionnaire.
Methodology: A cross-sectional observational study was conducted among 385 participants from Chhatrapati Sambhajinagar, Maharashtra, all of whom had a history of COVID-19 infection following the inclusion and exclusion criteria. Consent was secured before the assessment. We evaluate the presence and severity of neurological complications in post COVID-19 patients by an Edinburgh Questionnaire. Data was analysed using Microsoft Excel.
Study design: An observational study.
Result: The average age of participants was 46.28 ± 16.87 years; 54.80% were male and 45.20% female. Study revealed that the most common neurological symptoms reported among total participants were fatigue (73.5%), muscle weakness (66.2%), and chronic pain (64.1%). In addition, participants exhibited memory impairments (19.48%), blackouts (20.26%), sensory disturbances (19.4%), as well as postural tremors (6.75) were also identified as the least prevalence complication. Gender analysis revealed a higher prevalence of symptoms among males (54.8%) compared to females (45.2%).
Conclusion: Neurological complications are highly prevalent among post-COVID-19 patients, with fatigue, weakness, and chronic pain being the most common manifestations. Early recognition and targeted neurorehabilitation strategies are critical for improving quality of life in post-COVID-19 patients. Greater awareness among healthcare providers and patients is necessary to ensure timely diagnosis and intervention.
Key Words: COVID-19, Neurological Complications, Post-COVID Syndrome, Edinburgh Questionnaire, Neurorehabilitation, Fatigue, Blackouts, Memory Impairment.
REFERENCES
[1]. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924.
https://doi.org/10.1016/j.ijantimicag.2020.105924
PMid:32081636 PMCid:PMC7127800
[2]. Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19) [Updated 2023 Aug 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
[3]. Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res. 2022 Jan;240(1):9-25.
https://doi.org/10.1007/s00221-021-06244-z
PMid:34694467 PMCid:PMC8543422
[4]. Mishra NP, Das SS, Yadav S, Khan W, Afzal M, Alarifi A, Kenawy ER, Ansari MT, Hasnain MS, Nayak AK. Global impacts of pre- and post-COVID-19 pandemic: Focus on socio-economic consequences. Sens Int. 2020;1:100042.
https://doi.org/10.1016/j.sintl.2020.100042
PMid:34766044 PMCid:PMC7510561
[5]. K Park. Park’s Textbook of Preventive and Social Medicine. 2021. 26th ed., India, Bhanot Publishers, 2021, pp. 191-204.
[6]. Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, Janjua T, Bosque-Varela P. Post-COVID 19 neurological syndrome: Implications for sequelae’s treatment. J Clin Neurosci. 2021 Jun;88:219-225.
https://doi.org/10.1016/j.jocn.2021.04.001
PMid:33992187 PMCid:PMC8031003
[7]. Wang YJ, Sun YR, Pei YH, Ma HW, Mu YK, Qin LH, Yan JH. The lymphatic drainage systems in the brain: a novel target for ischemic stroke? Neural Regen Res. 2023 Mar;18(3):485-491.
https://doi.org/10.4103/1673-5374.346484
PMid:36018151 PMCid:PMC9727443
[8]. Almutairi MM, Sivandzade F, Albekairi TH, Alqahtani F, Cucullo L. Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Front Med (Lausanne). 2021 Nov 24;8:745789.
https://doi.org/10.3389/fmed.2021.745789
PMid:34901061 PMCid:PMC8652056
[9]. Mahdy, Mohammed. Post COVID-19 Postural Tremor, a Possible Neurological Complication. Zagazig University Medical Journal, 2021;24.
https://doi.org/10.21608/zumj.2021.72324.2194
[10]. Payne R, Pring T, Hey M, Payne G, Greenhalgh T. Muscle weakness post-COVID: a practical guide for primary care. Br J Gen Pract. 2024 Nov 28;74(749):573-575.
https://doi.org/10.3399/bjgp24X740229
PMid:39609044 PMCid:PMC11611341
[11]. Ahmed M, Roy S, Iktidar MA, et al. Post-COVID-19 Memory Complaints: Prevalence and Associated Factors. Neurologia (Barcelona, Spain). 2022 Apr.
https://doi.org/10.1016/j.nrl.2022.03.007
PMCid:PMC9020525
[12]. McWilliam M, Samuel M, Alkufri FH. Neuropathic pain post-COVID-19: a case report. BMJ Case Rep. 2021 Jul 22;14(7):e243459.
https://doi.org/10.1136/bcr-2021-243459
PMid:34301704 PMCid:PMC8728379
[13]. Hassan L, Ahsan Z, Bint E Riaz H. An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog. Cureus. 2023 Mar 17;15(3):e36273.
https://doi.org/10.7759/cureus.36273
[14]. Shipston-Sharman O, Hoeritzauer I, Edwards M, Reuber M, Carson A, Stone J. Screening for functional neurological disorders by questionnaire. J Psychosom Res. 2019 Apr;119:65-73.
https://doi.org/10.1016/j.jpsychores.2019.02.005
PMid:30947820
[15]. Vakili K, Fathi M, Hajiesmaeili M, Salari M, Saluja D, Tafakhori A, Sayehmiri F, Rezaei-Tavirani M. Neurological Symptoms, Comorbidities, and Complications of COVID-19: A Literature Review and Meta-Analysis of Observational Studies. Eur Neurol. 2021;84(5):307-324.
https://doi.org/10.1159/000516258
PMid:34044408 PMCid:PMC8247834
[16]. Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L, O’Callaghan J, Thomson B, Connolly E, Argue R, Meaney JFM, Martin-Loeches I, Long A, Cheallaigh CN, Conlon N, Doherty CP, Campbell M. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024 Mar;27(3):421-432. Erratum in: Nat Neurosci. 2024 May;27(5):1019.
https://doi.org/10.1038/s41593-024-01644-0
PMid:38627595 PMCid:PMC11088991
[17]. Karki R, Kanneganti TD. The ‘cytokine storm’: molecular mechanisms and therapeutic prospects. Trends Immunol. 2021 Aug;42(8):681-705.
https://doi.org/10.1016/j.it.2021.06.001
PMid:34217595 PMCid:PMC9310545
[18]. Savla, S. R., Prabhavalkar, K. S., & Bhatt, L. K. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Review of Anti-Infective Therapy, 2021;19(11):1397-1413.
https://doi.org/10.1080/14787210.2021.1915129
PMid:33832398 PMCid:PMC8074652
[19]. Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic Hypotension: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 Sep 11;72(11):1294-1309.
https://doi.org/10.1016/j.jacc.2018.05.079
PMid:30190008
[20]. Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022 Jun;65(6):E31-E32.
https://doi.org/10.1002/mus.27554
PMid:35385125 PMCid:PMC9088382
[21]. Tyagi K, Rai P, Gautam A, Kaur H, Kapoor S, Suttee A, Jaiswal PK, Sharma A, Singh G, Barnwal RP. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders. Eur J Med Res. 2023 Aug 30;28(1):307.
https://doi.org/10.1186/s40001-023-01293-2
PMid:37649125 PMCid:PMC10469568
[22]. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022 Mar;101:93-135.
https://doi.org/10.1016/j.bbi.2021.12.020
PMid:34973396 PMCid:PMC8715665
[23]. Adingupu DD, Soroush A, Hansen A, Twomey R, Dunn JF. Brain hypoxia, neurocognitive impairment, and quality of life in people post-COVID-19. J Neurol. 2023 Jul;270(7):3303-3314.
https://doi.org/10.1007/s00415-023-11767-2
PMid:37210689 PMCid:PMC10200033
